デフォルト表紙
市場調査レポート
商品コード
1630720

服薬アドヒアランス市場の規模、シェア、成長分析、製品タイプ別、投薬タイプ別、配信モード別、エンドユーザー別、地域別 - 産業予測、2025~2032年

Medication Adherence Market Size, Share, Growth Analysis, By Product Type (Hardware, Software), By Medication Type (Cardiovascular Drugs, Diabetes Drugs), By Delivery Mode, By End-User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
服薬アドヒアランス市場の規模、シェア、成長分析、製品タイプ別、投薬タイプ別、配信モード別、エンドユーザー別、地域別 - 産業予測、2025~2032年
出版日: 2025年01月08日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

服薬アドヒアランスの世界市場規模は、2023年に45億米ドルと評価され、2024年の52億米ドルから2032年には164億6,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは15.5%で成長する見通しです。

世界の服薬アドヒアランス市場は、患者中心のケア重視の高まり、慢性疾患の罹患率の増加、ヘルスケアテクノロジーの進歩に後押しされ、大幅な拡大を経験しています。服薬アドヒアランスが不十分であるという継続的な課題により、効果的な治療結果が得られず、ヘルスケアコストが高騰しています。この重大な問題に対して、服薬アドヒアランス率を向上させることを目的とした革新的なソリューションやテクノロジーが次々と登場しています。このような積極的なアプローチは、アドヒアランスのジレンマに対処するだけでなく、服薬アドヒアランスの世界市場全体の成長を促進し、患者の関与と健康アウトカムの改善による有望な将来を示しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ
  • 規制情勢
  • 特許分析

服薬アドヒアランス市場規模:製品タイプ別

  • 市場概要
  • ハードウェア
    • スマート薬ボトル
    • スマート錠剤ディスペンサー
    • 電子医薬品パッケージ
  • ソフトウェア
    • 服薬管理アプリ
    • 電子健康記録(EHR)の統合
  • サービス
    • 薬剤療法管理
    • 患者教育とトレーニング

服薬アドヒアランス市場規模:投薬タイプ別

  • 市場概要
  • 心臓血管薬
  • 糖尿病薬
  • 呼吸器薬
  • 中枢神経系(CNS)薬
  • 腫瘍治療薬
  • その他

服薬アドヒアランス市場規模:配信モード別

  • 市場概要
  • オンプレミス
  • クラウドベース

服薬アドヒアランス市場規模:エンドユーザー別

  • 市場概要
  • 病院
  • 薬局
  • 在宅ヘルスケア
  • 調査機関
  • その他

服薬アドヒアランス市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Omnicell, Inc.(United States)
  • Koninklijke Philips N.V.(Netherlands)
  • Medtronic plc(Ireland)
  • McKesson Corporation(United States)
  • Cerner Corporation(United States)
  • Becton, Dickinson and Company(United States)
  • Johnson & Johnson Services, Inc.(United States)
  • Novartis International AG(Switzerland)
  • Siemens Healthineers AG(Germany)
  • AdhereTech Inc.(United States)
  • SMRxT Inc.(United States)
  • Pillsy Inc.(United States)
  • TruMed Systems Inc.(United States)
  • Proteus Digital Health(United States)
  • Allscripts Healthcare Solutions, Inc.(United States)
  • MedMinder(United States)
  • Caredose(United States)
  • PHC Holdings Corporation(Japan)
  • Kakehashi Inc.(Japan)

結論と推奨事項

目次
Product Code: SQMIG35F2015

Global Medication Adherence Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 5.2 billion in 2024 to USD 16.46 billion by 2032, growing at a CAGR of 15.5% during the forecast period (2025-2032).

The global medication adherence market is experiencing significant expansion, fueled by a heightened emphasis on patient-centric care, a growing incidence of chronic diseases, and advancements in healthcare technology. The ongoing challenge of poor medication adherence has resulted in ineffective treatment outcomes and escalating healthcare costs. In response to this critical issue, an array of innovative solutions and technologies has emerged, aimed at enhancing medication adherence rates. This proactive approach not only addresses the adherence dilemma but also propels the overall growth of the global medication adherence market, indicating a promising future driven by patient engagement and improved health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medication Adherence market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medication Adherence Market Segmental Analysis

Global Medication Adherence Market is segmented by Product Type, Medication Type, Delivery Mode, End-User and region. Based on Product Type, the market is segmented into Hardware, Software and Services. Based on Medication Type, the market is segmented into Cardiovascular Drugs, Diabetes Drugs, Respiratory Drugs, Central Nervous System (CNS) Drugs, Oncology Drugs and Others. Based on Delivery Mode, the market is segmented into On-Premise and Cloud-Based. Based on End-User, the market is segmented into Hospitals, Pharmacies, Home Healthcare, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Medication Adherence Market

The Global Medication Adherence market is being significantly propelled by the rising burden of chronic diseases, including diabetes, cardiovascular conditions, respiratory disorders, and cancer. As these conditions become more prevalent, the need for effective long-term medication adherence strategies intensifies to ensure optimal treatment outcomes and enhance patient health. The aging population, which is particularly vulnerable to chronic illnesses and often requires multiple medications for effective disease management, further amplifies this demand. Medication adherence solutions are essential in assisting older adults in managing their medication schedules effectively, thereby reducing the risk of complications associated with improper medication use and improving overall health outcomes.

Restraints in the Global Medication Adherence Market

The Global Medication Adherence market faces significant restraints, particularly due to apprehensions surrounding privacy and data security. With the increasing integration of digital health technologies in medication adherence solutions, there are growing concerns regarding the safeguarding of patient information. Healthcare providers and solution developers must prioritize these issues, as they are crucial for fostering trust and maintaining patient confidentiality. Addressing these concerns is essential to ensure the successful implementation and adoption of medication adherence solutions, as any breach or perception of insecurity could hinder market growth and patient cooperation in adhering to treatment plans.

Market Trends of the Global Medication Adherence Market

The Global Medication Adherence market is experiencing a notable trend towards remote patient monitoring, driven by the surge in telehealth services. The COVID-19 pandemic accelerated the adoption of virtual healthcare, making it crucial for healthcare providers to ensure patient compliance with medication regimens. Advanced technologies, including mobile apps and wearables, enable healthcare professionals to monitor adherence in real-time and deliver timely interventions or reminders, thereby enhancing patient outcomes. As healthcare systems increasingly prioritize patient engagement and outcomes, the integration of remote monitoring solutions is expected to reshape the medication adherence landscape, fostering a more proactive and personalized approach to patient care.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Patent Analysis

Global Medication Adherence Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Hardware
    • Smart Pill Bottles
    • Smart Pill Dispensers
    • Electronic Medication Packaging
  • Software
    • Medication Management Apps
    • Electronic Health Records (EHR) Integration
  • Services
    • Medication Therapy Management
    • Patient Education & Training

Global Medication Adherence Market Size by Medication Type & CAGR (2025-2032)

  • Market Overview
  • Cardiovascular Drugs
  • Diabetes Drugs
  • Respiratory Drugs
  • Central Nervous System (CNS) Drugs
  • Oncology Drugs
  • Others

Global Medication Adherence Market Size by Delivery Mode & CAGR (2025-2032)

  • Market Overview
  • On-Premise
  • Cloud-Based

Global Medication Adherence Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Pharmacies
  • Home Healthcare
  • Research Institutes
  • Others

Global Medication Adherence Market Size & CAGR (2025-2032)

  • North America (Product Type, Medication Type, Delivery Mode, End-User)
    • US
    • Canada
  • Europe (Product Type, Medication Type, Delivery Mode, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Medication Type, Delivery Mode, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Medication Type, Delivery Mode, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Medication Type, Delivery Mode, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Omnicell, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • McKesson Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerner Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Services, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis International AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AdhereTech Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SMRxT Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pillsy Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TruMed Systems Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteus Digital Health (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allscripts Healthcare Solutions, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedMinder (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Caredose (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PHC Holdings Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kakehashi Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations